Tumor Immunotherapy
Cancer Vaccines
Targeted Cancer Therapies
Targeted Cancer Therapies
Cancer Therapies
Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 1, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
1Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine.
Cancer immunotherapies like immune checkpoint blockade and adoptive T-cell therapy show durable responses in advanced cancers. These treatments targeting CTLA-4 and PD-1/PD-L1 offer new hope for various malignancies.
Area of Science: